Project Description
Imatinib Mesylate
Mechanism of action:
Tyrosine kinase inhibitor (specific for abnormal BCR-ABL tyrosine kinase produced by Philadelphia chromosome in CML/ALL)
Indications:
Acute lymphoblastic leukemia, Chronic myelogenous leukemia, Gastrointestinal stromal tumors, Dermatofibrosarcoma protuberans, Systemic mastocytosis.
Chemical Name:
methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
Details
Molecular Weight:
589.7 g/mol
Molecular Formula:
C30H35N7O4S
CAS:No
220127-57-1
Product Type:
Powder